Reauthorization of the Pandemic All Hazards Preparedness Act, industrial base expansion Legislation related to drug pricing, drug price transparency and PBMS Implementation of the IRA, drug pricing provisions Legislation related to supply chains associated with active pharmaceutical ingredients and pharmaceuticals
2025 · 1st Quarter (Jan 1 - Mar 31)
MALLINCKRODT
Filed by ALPINE GROUP PARTNERS, LLC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ALPINE GROUP PARTNERS, LLC.
- Client
- MALLINCKRODT
- Filing UUID
- 1c0e7973-9061-4813-8dfb-4d292f7c4b02
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the drug supply chains
Tax incentives for the onshoring of APIs and essential medicines
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.